Azimilide is an investigational class III anti-arrhythmic drug that blocks fast and slow components of the delayed rectifier cardiac potassium channels. It is not approved for use in any country, but is currently in clinical trials in the United States.
Azimilide is an investigational class III anti-arrhythmic drug that blocks fast and slow components of the delayed rectifier cardiac potassium channels. It is not approved for use in any country, but is currently in clinical trials in the United States.
用于转复防止房扑、房颤、室上性心动过速的复发和减少近期心肌梗死患者发生心律失常性猝死的危险。
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.